|
WDR5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87469999968215E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36679999995781E-06 |
| Normal-vs-Stage2 |
7.58290000000272E-05 |
| Normal-vs-Stage3 |
1.10369999806181E-08 |
| Normal-vs-Stage4 |
3.29349999494966E-08 |
| Stage1-vs-Stage2 |
8.234800E-01 |
| Stage1-vs-Stage3 |
1.039510E-02 |
| Stage1-vs-Stage4 |
2.982400E-02 |
| Stage2-vs-Stage3 |
5.665900E-02 |
| Stage2-vs-Stage4 |
6.763900E-02 |
| Stage3-vs-Stage4 |
8.320000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.1670999973451E-08 |
| Normal-vs-AfricanAmerican |
3.681100E-03 |
| Normal-vs-Asian |
2.03769999999048E-05 |
| Caucasian-vs-AfricanAmerican |
2.651600E-01 |
| Caucasian-vs-Asian |
2.227400E-01 |
| AfricanAmerican-vs-Asian |
8.556000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.28939999957767E-07 |
| Normal-vs-Female |
2.66939999993276E-07 |
| Male-vs-Female |
6.582800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.37920000046144E-07 |
| Normal-vs-Age(41-60Yrs) |
9.28099999963905E-07 |
| Normal-vs-Age(61-80Yrs) |
6.35979999774605E-08 |
| Normal-vs-Age(81-100Yrs) |
2.417300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.503600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.266000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.852430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.782230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.896370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.780400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.74029999999914E-05 |
| Classical-VS-Follicular |
8.270300E-02 |
| Classical-VS-Other |
8.584400E-01 |
| Classical-VS-Normal |
7.15089999991925E-07 |
| Tall-VS-Follicular |
2.48599999996824E-06 |
| Tall-VS-Other |
2.388000E-01 |
| Tall-VS-Normal |
9.46219769204504E-11 |
| Follicular-VS-Other |
4.941000E-01 |
| Follicular-VS-Normal |
3.420700E-04 |
| Other-VS-Normal |
3.432000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70550000003311E-06 |
| Normal-vs-N1 |
3.28359999968164E-07 |
| N0-vs-N1 |
1.593750E-01 |
|
|
